87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Shrunken genomes may drive rapid cancer evolution and poor outcomes

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa
New targeted combination in people with relapsed acute myeloid leukemia shows promise

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre
Screening with a multi-cancer blood test reduced the most advanced cancers

Screening with a multi-cancer blood test reduced the most advanced cancers

by Louise Vennells,University of ExeterNHS Galleri study nurse with participant. Credit: University of ExeterA large-scale trial looking into the use of a blood test to see if it can help the NHS dete

Screening with a multi-cancer blood test reduced the most advanced cancers

by Louise Vennells,University of ExeterNHS Galleri study nurse with participant. Credit: University of ExeterA large-scale trial looking into the use of a blood test to see if it can help the NHS dete
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death

Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death

byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep

Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death

byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep
Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and
Simple leukemia treatment change in India cuts early child deaths

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm
A single clonal starting point may explain how multiple cervical cancer subtypes arise

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul
Physician experts call for systems-based approach to prostate cancer screening decisions

Physician experts call for systems-based approach to prostate cancer screening decisions

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Anna Tarazevich from PexelsProstate cancer screening is one of the most common decisions men face in primary care, yet many pati

Physician experts call for systems-based approach to prostate cancer screening decisions

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Anna Tarazevich from PexelsProstate cancer screening is one of the most common decisions men face in primary care, yet many pati
First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase
Can AI beat breast cancer?

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia
Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp